PROGRESSIVE SUPRANUCLEAR PALSY(PSP)
Clinical trials for PROGRESSIVE SUPRANUCLEAR PALSY(PSP) explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE SUPRANUCLEAR PALSY(PSP) trials appear
Sign up with your email to follow new studies for PROGRESSIVE SUPRANUCLEAR PALSY(PSP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New spinal injection drug tested for rare brain disorder
Disease control CompletedThis early-stage trial tested a drug called NIO752 in 59 people with progressive supranuclear palsy (PSP), a rare brain disorder that affects movement and balance. The drug was given as a spinal injection to see if it is safe and how the body processes it. The main goal was to ch…
Matched conditions: PROGRESSIVE SUPRANUCLEAR PALSY(PSP)
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New PET tracers aim to spot tau tangles in rare brain disease
Diagnosis CompletedThis early-phase study tests two new imaging drugs, [18F]ABBV-964i and [18F]ABBV-965i, designed to light up tau protein buildup in the brain during a PET scan. Tau buildup is linked to Progressive Supranuclear Palsy (PSP), a rare movement and thinking disorder. The trial includes…
Matched conditions: PROGRESSIVE SUPRANUCLEAR PALSY(PSP)
Phase: EARLY_PHASE1 • Sponsor: Invicro • Aim: Diagnosis
Last updated Jul 12, 2026 00:00 UTC